Healthcare innovations company Antrum Biotech has integrated Integra Biosciences 'Pipetboy', a serological pipette controller, into its laboratories.
The pipetting aid has helped with the company’s liquid handling workflows, streamlining the commercialisation of a variety of healthcare products.
The company expects that this will have a lasting impact on the way disease is controlled and diagnosed.
Located at Groote Schuur Hospital in Cape Town, South Africa, Antrum Biotech is a small start-up focused on translating scientific research into point-of-care diagnostic tests.
The organisation specialises in respiratory and infectious diseases, and recently developed the IRISA-T assay – a novel diagnostic test for detecting /extrapulmonary TB (EPTB) – in response to shortfalls in current testing methods.
The company acquired a Pipetboy pro pipette controller to improve the efficiency of its liquid handling workflows.
Robbyn Mattei, laboratory scientist at Antrum Biotech, said: “Bringing new diagnostic tools to market can be a notoriously slow and challenging process, but one way to accelerate product development is by investing in efficient and reliable laboratory equipment.
“The pipetboy pro is lightweight, stable and easy to control, and the unique LED light feature is also useful, especially when we are trying to aspirate and dispense accurate liquid volumes in more dimly lit spaces."
